Kridin et al. (2021) recently analyzed outcomes of COVID-19 in patients with psoriasis treated with anti-TNF biologics and found that TNF blockade significantly decreased the risk of COVID-19-associated hospitalization (Ablamunits and Lepsy, 2022). Here, TNF is linked to COVID-19.